BioPharmSignal logoBioPharmSignal

Biotech News

LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026

LeMaitre Vascular (LMAT)LeMaitre VascularEarnings

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2026 financial results on Wednesday, November 4, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook.

Related news

SENSSenseonics2026-10-21 12:00 EST

Senseonics Holdings, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call for November 9, 2026 at 4:30 P.M. Eastern Time

HYPRHyperfine2026-10-08 11:30 EST

Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026

CVRXCVRx2026-10-22 20:30 EST

CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026

PLSEPulse Biosciences2026-10-22 20:05 EST

Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026

ICUIICU Medical2026-10-22 12:30 EST

ICU Medical Announces Time of Third Quarter 2026 Earnings Conference Call

SGHTSight Sciences2026-10-21 20:05 EST

Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026

OMOutset Medical2026-10-21 20:05 EST

Outset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026

SHCSotera Health2026-10-21 11:00 EST

Sotera Health Announces Third-Quarter 2026 Earnings Release Date

RXSTRxSight2026-10-20 20:05 EST

RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3

STXSStereotaxis2026-10-20 11:40 EST

Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026

View all latest news

LeMaitre Vascular

Vascular Device Company LeMaitre Vascular develops devices, implants, and services used by vascular surgeons to treat peripheral vascular disease. Its portfolio is focused on open surgical and endovascular procedures outside the heart. Grafts and Biological Implants The company offers synthetic vascular grafts, Artegraft biological...

Recent company news

LMATLeMaitre Vascular2026-10-12 20:49 EST

LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026

LMATLeMaitre Vascular2026-08-27 20:51 EST

LeMaitre to Participate at Upcoming Investor Conferences in September

LMATLeMaitre Vascular2026-08-06 21:15 EST

LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

LMATLeMaitre Vascular2026-08-04 20:05 EST

LeMaitre Q2 2026 Financial Results

LMATLeMaitre Vascular2026-07-14 21:43 EST

LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026

Stock data

Close
83.67 USD
Market cap
2.09B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States